• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

CS MEDICA A/S: CS MEDICA has signed a distributor agreement with Slovenia based NaturaMedica

Read the release

CS MEDICA ("CS MEDICA" or the "Company") announces today that the Company has signed an distributor agreement with NaturaMedica. The agreement covers the territory of Slovenia and includes 4 of CS MEDICA's medical device products under the CANNASEN brand.  The order amounts to 20,700 units, corresponding to DKK 0,9 million in revenue which will be distributed over a 3.5-year period.

Lone Henriksen, CEO of CS MEDICA, pronounces:

"I am very glad to announce that CS MEDICA continues to expand on the European market. The Agreement with NaturaMedica demonstrates that our products are wanted and gives us a broader customer base in Europe. We hope that this agreement will spark more interest around Europe as we continue our expansion."

CS MEDICA reveals today that the Company has signed a distributor agreement with NaturaMedica. NaturaMedica (https://eur05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.naturamedica.si%2F&data=05%7C01%7C%7C06f4700858d845b39b6c08da582da188%7C1a85fb5101ea4c1581b68ca5cc0404f6%7C0%7C0%7C637919250267065005%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=OZ6MT3CsKh0oez6mTXmsL1HAeZmT0jq%2BNXGVb0vdgqQ%3D&reserved=0) is a company with a great network and extensive market know-how in Slovenia, covering both pharmacies and connections to associations as well as doctors. The focus will be on the Arthritis Gel and Pain Patch as the first launch followed by Psoriasis Gel and Nasal Spray Night later this year.

The order corresponds to DKK 0,9 million in revenue which will be distributed over a 3.5-year period. A breakdown of the annual order allocation is disclosed below.

2022:   3,200 units

2023:   3,500 units

2023:   3,600 units

2024: 10,400 units

CS MEDICA's products will be introduced to the Slovenian market later, after this summer.
 

This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-06-2022 08:05 CET.